You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Myelomonocytic, Juvenile

Showing 1 - 25 of 5,185
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Higher Risk Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial (AMG 176, Azacitidine)

Not yet recruiting
  • Higher Risk Myelodysplastic Syndrome
  • Chronic Myelomonocytic Leukemia
  • (no location specified)
Jul 29, 2022

Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia Trial in New York (Fludarabine, Busulfan,

Completed
  • Acute Myelogenous Leukemia
  • +2 more
  • New York, New York
    Columbia University Medical Center
Aug 4, 2021

Leukemia, Leukemia, Myeloid, Monocytic Leukemia Trial in Palo Alto (Enasidenib mesylat dose escalation)

Recruiting
  • Leukemia
  • +2 more
  • Enasidenib mesylat dose escalation
  • Palo Alto, California
    Stanford Cancer Institute
May 12, 2022

MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial (RP7214)

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • (no location specified)
Aug 17, 2022

MDS, Chronic Myelomonocytic Leukemia-2, Secondary Acute Myeloid Leukemia Trial in Nanjing (unrelated umbilical cord blood)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • unrelated umbilical cord blood
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Oct 16, 2022

Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Houston

Recruiting
  • Chronic Myelomonocytic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 4, 2022

MDS, Chronic Myelomonocytic Leukemia, Stem Cell Leukemia Trial in Boston (Inqovi)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 29, 2021

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Houston (DSP107, Azacitidine, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • DSP107
  • +2 more
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center, Department of
Jan 27, 2022

Chronic Myelomonocytic Leukemia-0, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Houston

Recruiting
  • Chronic Myelomonocytic Leukemia-0
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 18, 2022

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Finland (Bexmarilimab, Azacitidine, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Helsinki, Finland
  • +3 more
Jun 29, 2022

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Trial in Houston (Decitabine and Cedazuridine, Venetoclax)

Recruiting
  • Chronic Myelomonocytic Leukemia
  • Myelodysplastic Syndrome
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Recurrent Chronic Myelomonocytic Leukemia, Refractory Chronic Myelomonocytic Leukemia Trial in Rochester (Biospecimen

Not yet recruiting
  • Recurrent Chronic Myelomonocytic Leukemia
  • Refractory Chronic Myelomonocytic Leukemia
  • Biospecimen Collection
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Sep 19, 2022

Myelomonocytic Leukemia Trial in Villejuif (Deuterium Glucose)

Recruiting
  • Myelomonocytic Leukemia
  • Deuterium Glucose
  • Villejuif, Val De Marne, France
    Gustave Roussy
Feb 26, 2021

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial (LP-108, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • (no location specified)
Nov 29, 2022

Azacitidine in International Prognostic Scoring System

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
    • Tianjin, Tianjin, China
    • +2 more
    Jun 28, 2022

    Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

    Completed
    Has Results
    • Chronic Myelomonocytic Leukemia
    • +4 more
    • Imatinib Mesylate (Gleevec)
    • Houston, Texas
      UT MD Anderson Cancer Center
    Dec 7, 2021

    Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Birmingham (NTX-301)

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Dec 6, 2021

    MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Myeloproliferative Chronic Myelomonocytic Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    May 3, 2022

    Refractory Chronic Myelomonocytic Leukemia, Refractory Myelodysplastic Syndrome Trial in Houston (Fostamatinib)

    Recruiting
    • Refractory Chronic Myelomonocytic Leukemia
    • Refractory Myelodysplastic Syndrome
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 31, 2021

    Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts Trial (Biospecimen

    Not yet recruiting
    • Chronic Myelomonocytic Leukemia
    • +3 more
    • Biospecimen Collection
    • +3 more
    • (no location specified)
    Oct 27, 2022

    MDS, Chronic Myelomonocytic Leukemia (CMML) Trial (SNS-301)

    Withdrawn
    • Myelodysplastic Syndromes
    • Chronic Myelomonocytic Leukemia (CMML)
    • (no location specified)
    Aug 9, 2021

    Severe/Moderate Coronavirus, Chronic Myelomonocytic Leukemia, MDS Trial in Villejuif (Blood samples)

    Not yet recruiting
    • Severe/Moderate Coronavirus
    • +3 more
    • Blood samples
    • Villejuif, France
      Gustave Roussy Institut
    Dec 20, 2021

    Acute Myeloid Leukaemia; MDS;Chronic Myelomonocytic Leukemia Trial in Shenzhen (Azacytidine, HAG Regimen, Azacytidine)

    Recruiting
    • Acute Myeloid Leukaemia; Myelodysplastic Syndromes;Chronic Myelomonocytic Leukemia
    • Shenzhen, Guangdong, China
      Shenzhen Second People's Hospital
    Mar 14, 2022

    Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia Trial (GVHD prevention: post-transplantation

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +5 more
    • GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor
    • (no location specified)
    Aug 23, 2022

    Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML) Trial in Tampa (PF-04449913)

    Completed
    Has Results
    • Myelodysplastic Syndrome (MDS)
    • Chronic Myelomonocytic Leukemia (CMML)
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jun 10, 2021